IDiyas

For the Inventor, By the Inventor

Libertyville, IL, United States of America

James B Summers, Jr

USPTO Granted Patents = 27

Average Co-Inventor Count = 2.5

ph-index = 13

Forward Citations = 469(Granted Patents)


Company Filing History:

goldMedal27 out of 4,177 
 
Abbott Laboratories Corporation
 patents

Years Active: 1986-1999

Loading Chart...
27 patents (USPTO):Explore Patents
1. 5952320 - Macrocyclic inhibitors of matrix metalloproteinases and TNF.alpha. (1999-09-14),
2. 5665777 - Biphenyl hydroxamate inhibitors of matrix metalloproteinases (1997-09-09),
3. 5654305 - Indole piperazine platelet activating factor antagonists (1997-08-05),
4. 5643922 - Indole cyclohexyl platelet activating factor antagonists (1997-07-01),
5. 5567711 - Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet (1996-10-22),
6. 5486525 - Platelet activating factor antagonists: imidazopyridine indoles (1996-01-23),
7. 5459152 - Platelet activating factor antagonists (1995-10-17),
8. 5382670 - Platelet activating factor antagonists (1995-01-17),
9. 5250565 - Indole-,benzofuran-,and benzothiophene-containing (1993-10-05),
10. 5220059 - Lipoxygenase-inhibiting compounds derived from non-steroidal (1993-06-15),
11. 5185363 - Urea based lipoxygenase inhibiting compounds (1993-02-09),
12. 5175183 - Lipoxygenase inhibiting compounds (1992-12-29),
13. 5149704 - Platelet activating antagonists (1992-09-22),
14. 5120751 - Benzoylphenyl pyridinylthiazolidine compounds as platelet activating (1992-06-09),
15. 5120749 - Platelet activating antagonists (1992-06-09),

Title: The Innovative Work of James B Summers, Jr: A Trailblazer in Medical Research

Introduction:

James B Summers, Jr, a prolific inventor in the medical field, hails from Libertyville, IL, United States. With an impressive tally of 27 patents to his name, Summers, Jr has been a driving force in revolutionizing treatments for a variety of diseases.

Latest Patents:

Among his latest patents are groundbreaking inventions such as the "Macrocyclic Inhibitors of Matrix Metalloproteinases and TNF.alpha" and "Biphenyl Hydroxamate Inhibitors of Matrix Metalloproteinases". These compounds have shown promise in inhibiting matrix metalloproteinases and TNF.alpha secretion, offering new avenues for addressing inflammatory disease states.

Career Highlights:

James B Summers, Jr is associated with Abbott Laboratories Corporation, a renowned player in the pharmaceutical industry. His tenure at Abbott Laboratories has been marked by a series of innovative discoveries that have pushed the boundaries of medical science.

Collaborations:

Throughout his career, Summers, Jr has collaborated with esteemed colleagues such as Steven K Davidsen and George S Sheppard. These collaborations have fostered a rich exchange of ideas and have led to the development of groundbreaking solutions in the field of medical research.

Conclusion:

In conclusion, James B Summers, Jr stands as a true pioneer in the realm of medical inventions. His dedication to pushing the envelope of innovation and his collaborative spirit have solidified his position as a trailblazer in the field. The impact of his work continues to resonate across the medical community, offering hope and healing to countless individuals worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…